Skip to main content
Canna~Fangled Abstracts

Cannabidiol but not cannabidiolic acid reduces behavioural sensitisation to methamphetamine in rats, at pharmacologically effective doses

By April 18, 2022No Comments

. 2022 Apr 18.

doi: 10.1007/s00213-022-06119-3.

Online ahead of print.
Laísa S Umpierrez # 1, Priscila A Costa # 1, Eden A Michelutti 1, Sarah J Baracz 1, Melanie Sauer 1, Anita J Turner 1, Nicholas A Everett 1, Jonathon C Arnold 2 3, Iain S McGregor 2 3, Jennifer L Cornish 4
Affiliations 

Abstract

Rationale: Cannabidiol (CBD) and cannabidiolic acid (CBDA) are non-psychoactive components of the cannabis plant. CBD has been well characterised to have anxiolytic and anticonvulsant activity, whereas the behavioural effects of CBDA are less clear. Preclinical and clinical data suggests that CBD has antipsychotic properties and reduces methamphetamine self-administration in rats. An animal model that is commonly used to mimic the neurochemical changes underlying psychosis and drug dependence is methamphetamine (METH) sensitisation, where repeated administration of the psychostimulant progressively increases the locomotor effects of METH.

Objective: The aim of this study was to determine whether CBD or CBDA attenuate METH-induced sensitisation of locomotor hyperactivity in rats.

Methods: Eighty-six male Sprague Dawley rats underwent METH sensitisation protocol where they were subjected to daily METH (1 mg/kg on days 2 and 8, 5 mg/kg on days 3-7; i.p.) injections for 7 days. After 21 days of withdrawal, rats were given a prior injection of CBD (0, 40 and 80 mg/kg; i.p.) or CBDA (0, 0.1, 10 and 1000 µg/kg; i.p.) and challenged with acute METH (1 mg/kg; i.p.). Locomotor activity was then measured for 60 min.

Results: Rats displayed robust METH sensitisation as evidenced by increased locomotor activity to METH challenge in METH-pretreated versus SAL-pretreated rats. CBD (40 and 80 mg/kg) reduced METH-induced sensitisation. There was no effect of any CBDA doses on METH sensitisation or acute METH-induced hyperactivity.

Conclusion: These results demonstrate that CBD, but not CBDA, reduces METH sensitisation of locomotor activity in rats at pharmacologically effective doses, thus reinforcing evidence that CBD has anti-addiction and antipsychotic properties.

Keywords: Cannabidiol, Cannabidiolic acid, Locomotor activity, Methamphetamine, Psychosis, Sensitisation

References

    1. Ago Y, Nakamura S, Uda M et al (2006) Attenuation by the 5-HT1A receptor agonist osemozotan of the behavioral effects of single and repeated methamphetamine in mice. Neuropharmacology 51(4):914–922 – DOI
    1. Ago Y, Tanaka T, Kita Y, Tokumoto H, Takuma K, Matsuda T (2012) Lithium attenuates methamphetamine-induced hyper-locomotion and behavioral sensitization via modulation of prefrontal monoamine release. Neuropharmacology 62:1634–1639 – DOI
    1. Akiyama K, Saito A, Shimoda K (2011) Chronic methamphetamine psychosis after long-term abstinence in Japanese incarcerated patients. Am J Addict 20:240–249 – DOI
    1. Allen P, Chaddock CA, Egerton A et al (2016) Resting hyperperfusion of the hippocampus, midbrain, and basal ganglia in people at high risk for psychosis. Am J Psychiatry 173:392–399 – DOI
    1. Anderson LL, Low IK, Banister SD, McGregor IS, Arnold JC (2019a) Pharmacokinetics of phytocannabinoid acids and anticonvulsant effect of cannabidiolic acid in a mouse model of Dravet syndrome. J Nat Prod 22;82(11):3047–3055

Leave a Reply